Granted Patent
B2
US 12,492,400 · App. 17/543,018 · Granted Dec 9, 2025
Compositions and methods for induced tissue regeneration in mammalian species
Inventors:
Michael D. West (Mill Valley, CA); Karen Chapman (Mill Valley, CA); Hal Sternberg (Berkeley, CA)
Assignee:
Reverse BioEngineering, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Aspects of the present invention include methods and compositions related to the modulation of molecules regulating the regenerative potential of cells and tissues in the embryonic state and the loss thereof in later fetal and adult stages of development. The methods and compositions have uses in research in stem cell biology and in increasing regenerative potential in fetal and adult tissues otherwise incapable of regeneration.
Claims (17)
1 . A method of increasing regenerative potential of mammalian connective tissue ex vivo or in vitro comprising administering to the cells of the tissue a composition comprising a de-differentiation gene of OXTR and one or more de-differentiation genes selected from the group consisting of SOX2, KLF4, OCT4, MYC, NANOG, and LIN28, wherein one or more viral vectors comprise the one or more de-differentiation genes.
2 . The method of claim 1 , wherein the de-differentiation genes are OXTR, SOX2, KLF4, OCT4, MYC, NANOG, and LIN28.
3 . The method of claim 1 , wherein the method further comprises administering to the cells of the connective tissue a composition comprising one or more de-differentiation genes selected from the group consisting of PCDHB2, PCDHB17, Nbla10527, RAB3IP, DLX1, DRD11P, FOXD1, LOC728755, AFF3, F2RL2, MN1, CBCAQHO3 5′, LOC791120, SIX1, and WSB1, wherein one or more viral vectors comprise the one or more de-differentiation genes.
4 . The method of claim 3 , wherein the additional de-differentiation genes comprise PCDHB2, PCDHB17, RAB3IP, DLX1, DRD11P, and SIX1.
5 . The method of claim 3 , wherein the additional de-differentiation genes is SIX1.
6 . The method of claim 1 , wherein the mammalian tissue is from human.
7 . The method of claim 1 , wherein the connective tissue is damaged.
8 . The method of claim 7 , wherein the damaged connective tissue is a trauma wound, a surgical wound, or a wound associated with a disease.
9 . The method of claim 7 , wherein the damaged connective tissue is a burn, a scrape injury or other skin loss.
10 . The method of claim 7 , wherein the damaged connective tissue is associated with grafted skin.
11 . The method of claim 7 , wherein the damaged connective tissue involves a hair follicle or an epithelial cell.
12 . The method of claim 1 , wherein the one or more viral vectors are a retroviral vector, a lentiviral vector, or an adenoviral vector.
13 . The method of claim 1 , wherein the connective tissue is skin.
14 . A kit for enhancing regenerative potential of mammalian connective tissue wherein the kit comprises one or more de-differentiation genes of OXTR and one or more genes selected from the group consisting of SOX2, KLF4, OCT4, MYC, NANOG, and LIN28, wherein one or more viral vectors comprise the one or more genes.
15 . The kit of claim 14 , further comprising one or more of the genes selected from the group consisting of PCDHB2, PCDHB17, Nbla10527, RAB3IP, DLX1, DRD11P, FOXD1, LOC728755, AFF3, F2RL2, MN1, CBCAQHO3 5, LOC791120, SIX1, and WSB1.
16 . The kit of claim 14 , further comprising one or more compounds that form a hydrogel in situ.
17 . The kit of claim 16 , wherein the one or more compounds comprises a monomer, polymer, initiating agent, cross-linking agent or any combination thereof.
Assignments (5)
SECURITY INTEREST
Recorded Nov 10, 2023
From: AGEX THERAPEUTICS, INC.; RECYTE THERAPEUTICS, INC.; REVERSE BIOENGINEERING, INC.
To: JUVENESCENCE LIMITED
Reel/Frame 065529/0594 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 11, 2022
From: AGEX THERAPEUTICS, INC.
To: REVERSE BIOENGINEERING, INC.
Reel/Frame 059242/0007 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059211/0285 →
MERGER AND CHANGE OF NAME
Recorded Mar 9, 2022
From: BIOTIME, INC.; LINEAGE CELL THERAPEUTICS, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 059211/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 9, 2022
From: WEST, MICHAEL D.; CHAPMAN, KAREN; STERNBERG, HAL
To: BIOTIME, INC.
Reel/Frame 059211/0320 →
Continuity (4)
Continuation
14896664
Provisional Application
61831421
· Jun 5, 2013
References Cited (400)
US 5030015A
· Baker et al.
· 1991
[cited by applicant]
US 5489508A
· West et al.
· 1996
[cited by applicant]
US 5639613A
· Shay et al.
· 1997
[cited by applicant]
US 5686306A
· West et al.
· 1997
[cited by applicant]
US 5843780A
· Thomson
· 1998
[cited by applicant]
US 5922601A
· Baetscher et al.
· 1999
[cited by applicant]
US 6200806B1
· Thomson
· 2001
[cited by applicant]
US 6248934B1
· Tessier-Lavigne et al.
· 2001
[cited by applicant]
US 6280718B1
· Kaufman et al.
· 2001
[cited by applicant]
US 6333313B1
· Copland, III
· 2001
[cited by examiner]
US 6465493B1
· Burgess et al.
· 2002
[cited by applicant]
US 6602711B1
· Thomson et al.
· 2003
[cited by applicant]
US 6667176B1
· Funk et al.
· 2003
[cited by applicant]
US 6685911B1
· Zitvogel et al.
· 2004
[cited by applicant]
US 6887706B2
· Zhang et al.
· 2005
[cited by applicant]
US 7176023B2
· Kaufman et al.
· 2007
[cited by applicant]
US 7217569B2
· Thomson
· 2007
[cited by applicant]
US 7253334B2
· Collas et al.
· 2007
[cited by applicant]
US 7417041B2
· Blumberg et al.
· 2008
[cited by applicant]
US 7582479B2
· Thomson
· 2009
[cited by applicant]
US 7585622B1
· Cech et al.
· 2009
[cited by applicant]
US 7625573B2
· Zitvogel et al.
· 2009
[cited by applicant]
US 7736895B2
· Collas et al.
· 2010
[cited by applicant]
US 7928069B2
· Prestwich et al.
· 2011
[cited by applicant]
US 7951591B2
· Robl et al.
· 2011
[cited by applicant]
US 7981871B2
· Prestwich et al.
· 2011
[cited by applicant]
US 8021847B2
· Pietrzkowski
· 2011
[cited by applicant]
US 8058065B2
· Yamanaka et al.
· 2011
[cited by applicant]
US 8090542B2
· Khvorova et al.
· 2012
[cited by applicant]
US 8236774B2
· Cech et al.
· 2012
[cited by applicant]
US 8247384B2
· Green et al.
· 2012
[cited by applicant]
US 8324184B2
· Prestwich et al.
· 2012
[cited by applicant]
US 8476017B2
· Pietrzkowski
· 2013
[cited by applicant]
US 8685386B2
· West et al.
· 2014
[cited by applicant]
US 9175263B2
· Larocca et al.
· 2015
[cited by applicant]
US 20010039316A1
· Campbell et al.
· 2001
[cited by applicant]
US 20020001842A1
· Chapman
· 2002
[cited by applicant]
US 20020051762A1
· Rafii et al.
· 2002
[cited by applicant]
US 20020069484A1
· Creel
· 2002
[cited by applicant]
US 20020142397A1
· Collas et al.
· 2002
[cited by applicant]
US 20030046722A1
· Collas et al.
· 2003
[cited by applicant]
US 20030129745A1
· Robl et al.
· 2003
[cited by applicant]
US 20030149277A1
· Gaster et al.
· 2003
[cited by applicant]
US 20030161817A1
· Young et al.
· 2003
[cited by applicant]
US 20030166633A1
· Gaster et al.
· 2003
[cited by applicant]
US 20030180268A1
· Atala
· 2003
[cited by applicant]
US 20030232430A1
· Cibelli et al.
· 2003
[cited by applicant]
US 20040001807A1
· Edelberg et al.
· 2004
[cited by applicant]
US 20040039198A1
· Bender et al.
· 2004
[cited by applicant]
US 20040063745A1
· Gellibert et al.
· 2004
[cited by applicant]
US 20040152738A1
· Gaster et al.
· 2004
[cited by applicant]
US 20040199935A1
· Chapman
· 2004
[cited by applicant]
US 20040219563A1
· West et al.
· 2004
[cited by applicant]
US 20040220230A1
· Gaster et al.
· 2004
[cited by applicant]
US 20040228847A1
· Goldschmidt-Clermont et al.
· 2004
[cited by applicant]
US 20040247567A1
· Gurtner
· 2004
[cited by applicant]
US 20040266842A1
· Gaster et al.
· 2004
[cited by applicant]
US 20050014258A1
· Collas et al.
· 2005
[cited by applicant]
US 20050014938A1
· Gaster et al.
· 2005
[cited by applicant]
US 20050165011A1
· Gellibert et al.
· 2005
[cited by applicant]
US 20050250727A1
· Tasken et al.
· 2005
[cited by applicant]
US 20060003446A1
· Keller et al.
· 2006
[cited by applicant]
US 20060014147A1
· Golz
· 2006
[cited by examiner]
US 20060171930A1
· Seyda et al.
· 2006
[cited by applicant]
US 20060212952A1
· Collas et al.
· 2006
[cited by applicant]
US 20070072901A1
· Washio
· 2007
[cited by applicant]
US 20070116684A1
· Atala et al.
· 2007
[cited by applicant]
US 20070128174A1
· Kleinsek
· 2007
[cited by examiner]
US 20070154428A1
· Sato et al.
· 2007
[cited by applicant]
US 20070154474A1
· Soppet et al.
· 2007
[cited by applicant]
US 20070155013A1
· Akaike et al.
· 2007
[cited by applicant]
US 20080070303A1
· West et al.
· 2008
[cited by applicant]
US 20080233610A1
· Thomson
· 2008
[cited by applicant]
US 20090047263A1
· Yamanaka
· 2009
[cited by applicant]
US 20090104159A1
· Prosper et al.
· 2009
[cited by applicant]
US 20090148423A1
· Sumitran-Holgersson
· 2009
[cited by applicant]
US 20090220450A1
· Green et al.
· 2009
[cited by applicant]
US 20090269314A1
· Keller et al.
· 2009
[cited by applicant]
US 20100003757A1
· Mack
· 2010
[cited by applicant]
US 20100055678A1
· Jaatinen et al.
· 2010
[cited by applicant]
US 20100111914A1
· Zhang et al.
· 2010
[cited by applicant]
US 20100158872A1
· Keller et al.
· 2010
[cited by applicant]
US 20100166713A1
· Dalton et al.
· 2010
[cited by applicant]
US 20100167404A1
· West et al.
· 2010
[cited by applicant]
US 20100183620A1
· Bhawe et al.
· 2010
[cited by applicant]
US 20100184033A1
· West et al.
· 2010
[cited by applicant]
US 20100203021A1
· Goumans et al.
· 2010
[cited by applicant]
US 20100255580A1
· Rezania
· 2010
[cited by applicant]
US 20100267135A1
· Sakurada et al.
· 2010
[cited by applicant]
US 20100330063A1
· Weinstein
· 2010
[cited by examiner]
US 20110014620A1
· Basilico
· 2011
[cited by examiner]
US 20110038791A1
· Ford et al.
· 2011
[cited by applicant]
US 20110064701A1
· Young et al.
· 2011
[cited by applicant]
US 20110104133A1
· Tseng et al.
· 2011
[cited by applicant]
US 20110143441A1
· West et al.
· 2011
[cited by applicant]
US 20110218143A1
· Kaushal et al.
· 2011
[cited by applicant]
US 20110223669A1
· Yamanaka et al.
· 2011
[cited by applicant]
US 20110312881A1
· Silverman et al.
· 2011
[cited by applicant]
US 20120060232A1
· Stan
· 2012
[cited by applicant]
US 20120093885A1
· Sahoo et al.
· 2012
[cited by applicant]
US 20120148546A1
· Dar-Oaknin et al.
· 2012
[cited by applicant]
US 20120171171A1
· West et al.
· 2012
[cited by applicant]
US 20120295347A1
· Kessler
· 2012
[cited by applicant]
US 20120301443A1
· Raffi et al.
· 2012
[cited by applicant]
US 20120321671A1
· Boyden et al.
· 2012
[cited by applicant]
US 20130015622A1
· Hata
· 2013
[cited by applicant]
US 20130115609A1
· Ho
· 2013
[cited by applicant]
US 20130115673A1
· West et al.
· 2013
[cited by applicant]
US 20130196865A1
· Hochedlinger et al.
· 2013
[cited by applicant]
US 20130202564A1
· Han et al.
· 2013
[cited by applicant]
US 20130236961A1
· Amit et al.
· 2013
[cited by applicant]
US 20140010801A1
· Niedernhofer et al.
· 2014
[cited by applicant]
US 20140178988A1
· West et al.
· 2014
[cited by applicant]
US 20140349396A1
· West et al.
· 2014
[cited by applicant]
US 20150017718A1
· Nakatsuji et al.
· 2015
[cited by applicant]
US 20150079110A1
· Burns
· 2015
[cited by examiner]
US 20150202234A1
· Gillette et al.
· 2015
[cited by applicant]
US 20150232808A1
· West et al.
· 2015
[cited by applicant]
US 20150275177A1
· West et al.
· 2015
[cited by applicant]
US 20160002597A1
· Sinden et al.
· 2016
[cited by applicant]
US 20160108368A1
· Larocca et al.
· 2016
[cited by applicant]
US 20160193252A1
· Hicks et al.
· 2016
[cited by applicant]
US 20160305933A1
· Shigemoto
· 2016
[cited by applicant]
US 20160369237A1
· West et al.
· 2016
[cited by applicant]
US 20170108503A1
· Klass et al.
· 2017
[cited by applicant]
US 20170146529A1
· Nagrath et al.
· 2017
[cited by applicant]
US 20170239320A1
· Conboy
· 2017
[cited by examiner]
US 20180170982A1
· West et al.
· 2018
[cited by applicant]
US 20180273906A1
· Ashraf
· 2018
[cited by applicant]
US 20180280443A1
· Glicksman et al.
· 2018
[cited by applicant]
US 20190151372A1
· Larocca et al.
· 2019
[cited by applicant]
US 20190175691A1
· West et al.
· 2019
[cited by applicant]
US 20190218511A1
· Larocca et al.
· 2019
[cited by applicant]
US 20220088137A1
· West et al.
· 2022
[cited by applicant]
US 20220088138A1
· West et al.
· 2022
[cited by applicant]
US 20220098554A1
· Yang et al.
· 2022
[cited by applicant]
US 20220160833A1
· West et al.
· 2022
[cited by applicant]
US 20220401494A1
· Larocca et al.
· 2022
[cited by applicant]
US 20220403341A1
· Larocca et al.
· 2022
[cited by applicant]
US 20230093399A1
· West et al.
· 2023
[cited by applicant]
CN 102105789A
· 2011
[cited by applicant]
CN 104114693A
· 2014
[cited by applicant]
CN 104350146A
· 2015
[cited by applicant]
CN 105435244A
· 2016
[cited by applicant]
EP 1001806A1
· 2000
[cited by applicant]
EP 1523990A1
· 2005
[cited by applicant]
EP 1860180A1
· 2007
[cited by applicant]
EP 2254586A1
· 2010
[cited by applicant]
EP 2496711A2
· 2012
[cited by applicant]
EP 3387112A1
· 2018
[cited by applicant]
EP 3463391A1
· 2019
[cited by applicant]
JP 2013151437A
· 2013
[cited by applicant]
JP 2016518393A
· 2016
[cited by applicant]
JP 2019517538A
· 2019
[cited by applicant]
WO WO199830679A1
· 1998
[cited by applicant]
WO WO199903499A1
· 1999
[cited by applicant]
WO WO199920741A1
· 1999
[cited by applicant]
WO WO200100650A1
· 2001
[cited by applicant]
WO WO200130978A1
· 2001
[cited by applicant]
WO WO200151616A2
· 2001
[cited by applicant]
WO WO2003046141A2
· 2003
[cited by applicant]
WO WO2003074654A2
· 2003
[cited by applicant]
WO WO2003076603A2
· 2003
[cited by applicant]
WO WO2005068610A1
· 2005
[cited by applicant]
WO WO2005121369A2
· 2005
[cited by applicant]
WO WO2006054262A2
· 2006
[cited by applicant]
WO WO2006130504A2
· 2006
[cited by applicant]
WO WO2007019398A1
· 2007
[cited by applicant]
WO WO2007047894A2
· 2007
[cited by applicant]
WO WO2007058671A1
· 2007
[cited by applicant]
WO WO2007062198A1
· 2007
[cited by applicant]
WO WO2008089448A2
· 2008
[cited by applicant]
WO WO2008148938A1
· 2008
[cited by applicant]
WO WO2009052211A1
· 2009
[cited by applicant]
WO WO2009105044A1
· 2009
[cited by applicant]
WO WO2010021993A1
· 2010
[cited by applicant]
WO WO2011053257A2
· 2011
[cited by applicant]
WO WO2011150105A2
· 2011
[cited by applicant]
WO WO2012020308A2
· 2012
[cited by applicant]
WO WO2012065065A1
· 2012
[cited by applicant]
WO WO2012125471A1
· 2012
[cited by applicant]
WO WO2012147470A1
· 2012
[cited by applicant]
WO WO2013003595A1
· 2013
[cited by applicant]
WO WO2013014691A1
· 2013
[cited by applicant]
WO WO2013036969A1
· 2013
[cited by applicant]
WO WO2013082268A1
· 2013
[cited by applicant]
WO WO2013084000A2
· 2013
[cited by applicant]
WO WO2013150303A1
· 2013
[cited by applicant]
WO WO2013172793A1
· 2013
[cited by applicant]
WO WO2014013258A1
· 2014
[cited by applicant]
WO WO2014022852A1
· 2014
[cited by applicant]
WO WO2014028493A2
· 2014
[cited by applicant]
WO WO2014091373A1
· 2014
[cited by applicant]
WO WO2014125276A1
· 2014
[cited by applicant]
WO WO2014125277A1
· 2014
[cited by applicant]
WO WO2014197421A1
· 2014
[cited by applicant]
WO WO2015052526A1
· 2015
[cited by applicant]
WO WO2015052527A1
· 2015
[cited by applicant]
WO WO2017100313A1
· 2017
[cited by applicant]
WO WO2017214342A1
· 2017
[cited by applicant]
WO WO2019178296A1
· 2019
[cited by applicant]
WO WO2019209892A1
· 2019
[cited by applicant]
WO WO2020069373A1
· 2020
[cited by applicant]
Elabd et al. Nature Communications 5:4082 pp. 1-11 (Year: 2014).
[cited by examiner]
Ghosh et al. Applied Biosafety: Journal of ABSA International Vo. 25, 7-18 (Year: 2020).
[cited by examiner]
Abad et al., Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature. 2013;502(7471):340-345.
[cited by applicant]
Ahfeldt et al., Programming human pluripotent stem cells into white and brown adipocytes. Nat Cell Biol. Jan. 15, 2012;14(2):209-19.
[cited by applicant]
Alle et al., A single short reprogramming early in life improves fitness and increases lifespan in old age. bioRxiv, https://doi.org/10.1101/2021.05.13.443979. 56 pages, May 14, 2021.
[cited by applicant]
Amieux et al., Cyclic nucleotides converge on brown adipose tissue differentiation. Sci Signal. Jan. 12, 2010;3(104):pe2. 3 pages.
[cited by applicant]
Ancey et al., Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. Cytokine. May 21, 2002;18(4):199-205.
[cited by applicant]
Armulik et al., Pericytes regulate the blood-brain barrier. Nature. Nov. 25, 2010468(7323):557-61.
[cited by applicant]
Armulik et al., Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell. Aug. 16, 2011;21(2):193-215.
[cited by applicant]
Bai et al., BMP4 regulates vascular progenitor development in human embryonic stem cells through a Smad-dependent pathway. J Cell Biochem. Feb. 1, 2010;109(2):363-74.
[cited by applicant]
Beranger et al., In vitro brown and “brite”/“beige” adipogenesis: human cellular models and molecular aspects. Biochim Biophys Acta. May 2013;1831(5):905-14.
[cited by applicant]
Bergers et al., The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. Oct. 2005;7(4):452-64.
[cited by applicant]
Beyret et al., Elixir of Life: Thwarting Aging With Regenerative Reprogramming. Circ Res. Jan. 5, 2018;122(1):128-141.
[cited by applicant]
Bian et al., Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl). Apr. 2014;92(4):387-97.
[cited by applicant]
Bignone et al., Identification of human embryonic progenitor cell targeting peptides using phage display. PLoS One. 2013;8(3):e58200. 12 pages.
[cited by applicant]
Birbrair et al., Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells Dev. Aug. 15, 2013;22(16):2298-314.
[cited by applicant]
Birbrair et al., Type-2 pericytes participate in normal and tumoral angiogenesis. Am J Physiol Cell Physiol. Jul. 1, 2014;307(1):C25-38.
[cited by applicant]
Blanpain et al., Stem cells assessed. Nat Rev Mol Cell Biol. Jun. 8, 2012;13(7):471-6.
[cited by applicant]
Blocki et al., Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev. Sep. 1, 2013;22(17):2347-55.
[cited by applicant]
Bloom et al., Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promisin…
[cited by applicant]
Blum et al., The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle. Dec. 2009;8(23):3822-30.
[cited by applicant]
Bodnar et al., Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279(5349):349-352.
[cited by applicant]
Bogos et al., VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer. Clin Cancer Res. Mar. 1, 2009;15(5):1741-6.
[cited by applicant]
Bongso et al., Improved quality of human embryos when co-cultured with human ampullary cells. Hum Reprod. Aug. 1989;4(6):706-13.
[cited by applicant]
Bongso et al., Isolation and culture of inner cell mass cells from human blastocysts. Hum Reprod. Nov. 1994;9(11):2110-7.
[cited by applicant]
Bruno et al., Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. May 2009;20(5):1053-67.
[cited by applicant]
Camussi et al., Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. Nov. 2010;78(9):838-48.
[cited by applicant]
Cannon et al., Brown adipose tissue: function and physiological significance. Physiol Rev. Jan. 2004;84(1):277-359.
[cited by applicant]
Cannon et al., Cultures of adipose precursor cells from brown adipose tissue and of clonal brown-adipocyte-like cell lines. Methods Mol Biol. 2001;155:213-24.
[cited by applicant]
Carmeliet, Angiogenesis in life, disease and medicine. Nature. Dec. 15, 2005;438(7070):932-6.
[cited by applicant]
Chakritbudsabong et al., Exogenous LIN28 Is Required for the Maintenance of Self-Renewal and Pluripotency in Presumptive Porcine-Induced Pluripotent Stem Cells. Front Cell Dev Biol. Jul. 20, 2021;9:709286, 16 pages.
[cited by applicant]
Cheema et al., Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair Regen. May-Jun. 2007;15(3):286-95.
[cited by applicant]
Chen et al., A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. Jul.-Aug. 1986;17(4):738-43.
[cited by applicant]
Chen et al., Advances in the developmental origin of brown adipocyte. Chinese Bulletin of Life Sciences. Jul. 2013;25(7):661-668.
[cited by applicant]
Chen et al., Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. Apr. 25, 2011;9:47. 10 pages.
[cited by applicant]
Chen et al., Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity. Stem Cells. Feb. 2015;33(2):557-73.
[cited by applicant]
Chen et al., Human pericytes for ischemic heart repair. Stem Cells. Feb. 2013;31(2):305-16.
[cited by applicant]
Chiavellini et al., Aging and rejuvenation—a modular epigenome model. Aging (Albany NY). Feb. 24, 2021;13(4):4734-4746.
[cited by applicant]
Chiche et al., Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle. Cell Stem Cell. Mar. 2, 2017;20(3):407-414.e4.
[cited by applicant]
Chuang et al., The fission yeast homologue of Orc4p binds to replication origin DNA via multiple AT-hooks. Proc Natl Acad Sci U S A. 1999;96(6):2656-2661.
[cited by applicant]
Chung et al., Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell. Feb. 7, 2008;2(2):113-7.
[cited by applicant]
Cibelli et al., Transgenic bovine chimeric offspring produced from somatic cell-derived stem-like cells. Nat Biotechnol. Jul. 1998;16(7):642-6.
[cited by applicant]
Climent et al., TGFbeta Triggers miR-143/145 Transfer From Smooth Muscle Cells to Endothelial Cells, Thereby Modulating Vessel Stabilization. Circ Res. May 22, 2015;116(11):1753-64.
[cited by applicant]
Cohen et al., Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet. Apr. 2011;12(4):243-52.
[cited by applicant]
Conley et al., BMPs regulate differentiation of a putative visceral endoderm layer within human embryonic stem-cell-derived embryoid bodies. Biochem Cell Biol. Feb. 2007;85(1):121-32.
[cited by applicant]
Cooper et al., Modulation of PGC-1 coactivator pathways in brown fat differentiation through LRP130. J Biol Chem. Nov. 14, 2008;283(46):31960-7.
[cited by applicant]
Corselli et al., Identification of perivascular mesenchymal stromal/stem cells by flow cytometry. Cytometry A. Aug. 2013;83(8):714-20.
[cited by applicant]
Costa et al., The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods. Apr. 2005;2(4):259-60.
[cited by applicant]
Costa et al., The hESC line Envy expresses high levels of GFP in all differentiated progeny. Nat Methods. Apr. 2005;2(4):259-60. Advance online publication.
[cited by applicant]
Crisan et al., A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. Sep. 11, 2008;3(3):301-13.
[cited by applicant]
Crook et al., The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell. Nov. 2007;1(5):490-4.
[cited by applicant]
Cruz et al., Extracellular Vesicles: Decoding a New Language for Cellular Communication in Early Embryonic Development. Front Cell Dev Biol. Aug. 28, 2018;6:94.
[cited by applicant]
Dai et al., MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathway. PLoS One. Oct. 14, 2014;9(10):e108468. 14 pages.
[cited by applicant]
Daneman et al., Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature. Nov. 25, 2010;468(7323):562-6.
[cited by applicant]
Dar et al., Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation. Jan. 3, 2012;125(1):87-99.
[cited by applicant]
De Souza Batista et al., Omentin plasma levels and gene expression are decreased in obesity. Diabetes. Jun. 2007;56(6):1655-61.
[cited by applicant]
Dechesne et al., Stem Cells from Human Adipose Tissue: A New Tool for Pharmacological Studies and for Clinical Applications. Adipose Stem Cells and Regenerative Medicine. Y.-G. Illouz (Ed.), Springer-Verlag Berlin Heide…
[cited by applicant]
Deregibus et al., Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. Oct. 1, 2007;110(7):2440-8.
[cited by applicant]
Desandro et al., Associations and interactions between bare lymphocyte syndrome factors. Mol Cell Biol. Sep. 2000;20(17):6587-99.
[cited by applicant]
Dore-Duffy et al., Morphology and properties of pericytes. Methods Mol Biol. 2011;686:49-68.
[cited by applicant]
Dubois et al., SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol. Oct. 23, 2011;29(11):1011-8.
[cited by applicant]
Durick et al., Hunting with traps: genome-wide strategies for gene discovery and functional analysis. Genome Res. Nov. 1999;9(11):1019-25.
[cited by applicant]
Díez et al., Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res. Dec. 1, 2010;88(3):502-11.
[cited by applicant]
Elabd et al., Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes. Stem Cells. Nov. 2009;27(11):2753-60.
[cited by applicant]
Elali et al., The role of pericytes in neurovascular unit remodeling in brain disorders. Int J Mol Sci. Apr. 16, 2014;15(4):6453-74.
[cited by applicant]
Espandar et al., Adipose-derived stem cells on hyaluronic acid-derived scaffold: a new horizon in bioengineered cornea. Arch Ophthalmol. Feb. 2012;130(2):202-8.
[cited by applicant]
Fedorenko et al., Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell. Oct. 12, 2012;151(2):400-13.
[cited by applicant]
Ferrari et al., Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis. J Cell Physiol. May 2009;219(2):449-58.
[cited by applicant]
Fish et al., miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. Aug. 2008;15(2):272-84.
[cited by applicant]
Follenzi et al., Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet. Jun. 2000;25(2):217-22.
[cited by applicant]
Forte et al., MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus. J Virol. Feb. 2015;89(4):2333-41.
[cited by applicant]
Francavilla et al., Transient GFER knockdown in vivo impairs liver regeneration after partial hepatectomy. Int J Biochem Cell Biol. Aug. 2014;53:343-51.
[cited by applicant]
French et al., What is a Conservative Substitution? J Mol Evol. 1983;19:171-175.
[cited by applicant]
Fu et al., Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice. J Clin Invest. Nov. 2008;118(11):3725-37.
[cited by applicant]
Funk et al., Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomes. Stem Cell Res. Mar. 2012;8(2):154-64.
[cited by applicant]
Gao et al., Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science. Jan. 11, 2008;319(5860):195-8.
[cited by applicant]
Garbuzova-Davis et al., Blood-CNS Barrier Impairment in ALS patients versus an animal model. Front Cell Neurosci. Feb. 3, 2014;8:21. 10 pages.
[cited by applicant]
Garcia et al., Glucose Starvation in Cardiomyocytes Enhances Exosome Secretion and Promotes Angiogenesis in Endothelial Cells. PLoS One. Sep. 22, 2015;10(9):e0138849. 23 pages.
[cited by applicant]
Gardner et al., Culture and transfer of human blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril. Jan. 1998;69(1):84-8.
[cited by applicant]
Gehling et al., In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. May 15, 2000;95(10):3106-12.
[cited by applicant]
Genecards, ADIPOQ Gene. Retrieved online at: https://www.genecards.org/cgi-bin/carddisp.p?gene=ADIPOQ#protein_expression. 27 pages, 1996-2021.
[cited by applicant]
George et al., Isolation of human platelet membrane microparticles from plasma and serum. Blood. Oct. 1982;60(4):834-40.
[cited by applicant]
Ghaedi et al., Human Pluripotent Stem Cells (iPSC) Generation, Culture, and Differentiation to Lung Progenitor Cells. Methods Mol Biol. 2019;1576:55-92.
[cited by applicant]
Gill et al., Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. bioRxiv, https://doi.org/10.1101/2021.01.15.426786. 25 pages, Jan. 17, 2021.
[cited by applicant]
Goldman et al., A boost of BMP4 accelerates the commitment of human embryonic stem cells to the endothelial lineage. Stem Cells. Aug. 2009;27(8):1750-9.
[cited by applicant]
Golozoubova et al., Only UCP1 can mediate adaptive nonshivering thermogenesis in the cold. FASEB J. Sep. 2001;15(11):2048-50.
[cited by applicant]
Goumans et al., TGF-beta signaling in vascular biology and dysfunction. Cell Res. Jan. 2009;19(1):116-27.
[cited by applicant]
Greenwood-Goodwin et al., A novel lineage restricted, pericyte-like cell line isolated from human embryonic stem cells. Sci Rep. Apr. 25, 2016;6:24403, 10 pages.
[cited by applicant]
Grigolo et al., Transplantation of chondrocytes seeded on a hyaluronan derivative (hyaff-11) into cartilage defects in rabbits. Biomaterials. Sep. 2001;22(17):2417-24.
[cited by applicant]
Grützkau et al., Small but mighty: how the MACS-technology based on nanosized superparamagnetic particles has helped to analyze the immune system within the last 20 years. Cytometry A. Jul. 2010;77(7):643-7.
[cited by applicant]
Guduric-Fuchs et al., Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics. Aug. 1, 2012;13:357. 14 pages.
[cited by applicant]
Haflidadóttir et al., Upregulation of miR-96 enhances cellular proliferation of prostate cancer cells through FOXO1. PLoS One. Aug. 12, 2013;8(8):e72400. 11 pages.
[cited by applicant]
Han et al., Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. Antioxid Redox Signal. Oct. 1, 2011;15(7):1799-820.
[cited by applicant]
Harms et al., Brown and beige fat: development, function and therapeutic potential. Nat Med. Oct. 2013;19(10):1252-63.
[cited by applicant]
Hassan et al., Encapsulation and 3D culture of human adipose-derived stem cells in an in- situ crosslinked hybrid hydrogel composed of PEG-based hyperbranched copolymer and hyaluronic acid. Stem Cell Res Ther. Mar. 21, …
[cited by applicant]
Hedman et al., Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol. Apr. 1979;81(1):83-91.
[cited by applicant]
Hemmrich et al., Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials. Dec. 2005;26(34):7025-37.
[cited by applicant]
Heo et al., Spontaneous differentiation of mouse embryonic stem cells in vitro: characterization by global gene expression profiles. Biochem Biophys Res Commun. Jul. 15, 2005;332(4):1061-9.
[cited by applicant]
Herrera et al., Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. Jun. 2010;14(6B):1605-18.
[cited by applicant]
Ho et al., Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. Jan. 15, 2001;61(2):474-7.
[cited by applicant]
Honda et al., Cartilage formation by cultured chondrocytes in a new scaffold made of poly(L-lactide-epsilon-caprolactone) sponge. J Oral Maxillofac Surg. Jul. 2000;58(7):767-75.
[cited by applicant]
Horvath, DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115, 20 pages.
[cited by applicant]
Huber et al., Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature. Dec. 2, 2004;432(7017):625-30.
[cited by applicant]
Hynes et al., Micropatterning of 3D Microenvironments for Living Biosensor Applications. Biosensors (Basel). Mar. 2014;4(1):28-44.
[cited by applicant]
Hölig et al., Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. Protein Eng Des Sel. May 2004;17(5):433-41.
[cited by applicant]
Hüttemann et al., Mice deleted for heart-type cytochrome c oxidase subunit 7a1 develop dilated cardiomyopathy. Mitochondrion. Mar. 2012;12(2):294-304.
[cited by applicant]
Ibrahim et al., Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Reports. May 8, 2014;2(5):606-19.
[cited by applicant]
Inman et al., SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. Jul. 2002;62(1):65-74.
[cited by applicant]
Jackson et al., Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov. Jan. 2010;9(1):57-67.
[cited by applicant]
Jaiswal et al., Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol. Jan. 2003;21(1):47-51.
[cited by applicant]
Jakob et al., Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res. Mar. 15, 2012;93(4):614-22.
[cited by applicant]
James et al., An abundant perivascular source of stem cells for bone tissue engineering. Stem Cells Transl Med. Sep. 2012;1(9):673-84.
[cited by applicant]
James et al., Contribution of human embryonic stem cells to mouse blastocysts. Dev Biol. Jul. 1, 2006;295(1):90-102.
[cited by applicant]
James et al., Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFbeta inhibition is ld1 dependent. Nat. Biotechnol. Feb. 2010;28(2):161-6.
[cited by applicant]
Jankovic et al., Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc Natl Acad Sci U S A. Jan. 23, 2007;104(4):1260-5.
[cited by applicant]
Jeong et al., Nanovesicles engineered from ES cells for enhanced cell proliferation. Biomaterials. Nov. 2014;35(34):9302-10.
[cited by applicant]
Jun-Hao et al., Lin28 and let-7 in the Metabolic Physiology of Aging. Trends Endocrinol Metab. Mar. 2016;27(3):132-141.
[cited by applicant]
Kaczkowski et al., Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers. Cancer Res. 2016;76(2):216-226.
[cited by applicant]
Kane et al., Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol. Jul. 2010;30(7):1389-9…
[cited by applicant]
Kane et al., Epigenetic changes during aging and their reprogramming potential. Crit Rev Biochem Mol Biol. Feb. 2019;54(1):61-83.
[cited by applicant]
Kang et al., A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell. Apr. 2003;11(4):915-26.
[cited by applicant]
Karamanlidis et al., C/EBPbeta reprograms white 3T3-L1 preadipocytes to a Brown adipocyte pattern of gene expression. J Biol Chem. Aug. 24, 2007;282(34):24660-9.
[cited by applicant]
Kashyap et al., Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem c…
[cited by applicant]
Kawamoto et al., Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv. Oct. 1, 2007;70(4):477-84.
[cited by applicant]
Kawasaki et al., Vascular Repair by Tissue-Resident Endothelial Progenitor Cells in Endotoxin-Induced Lung Injury. Am J Respir Cell Mol Biol. Oct. 2015;53(4):500-12.
[cited by applicant]
Kazantzis et al., PAZ6 cells constitute a representative model for human brown pre-adipocytes. Front Endocrinol (Lausanne). Feb. 2, 2012;3:13.
[cited by applicant]
Keller et al., Exosomes: from biogenesis and secretion to biological function. Immunol Lett. Nov. 15, 2006;107(2):102-8.
[cited by applicant]
Kelly et al., Signaling hierarchy regulating human endothelial cell development. Arterioscler Thromb Vasc Biol. May 2009;29(5):718-24.
[cited by applicant]
Khakoo et al., Endothelial progenitor cells. Annu Rev Med. 2005;56:79-101.
[cited by applicant]
Kidder et al., Examination of transcriptional networks reveals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem cell maintenance. Genome Res. Apr. 2010;20(4):458-72.
[cited by applicant]
Kim et al., Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res. Nov. 1, 2002;62(21):6312-7.
[cited by applicant]
Kim et al., Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011-2015.
[cited by applicant]
King et al., Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. Sep. 24, 2012;12:421. 10 pages.
[cited by applicant]
Korchagin, Neoplastic Diseases Reviews, Stem Cells. CancerLink.ru. 26 pages, (2011).
[cited by applicant]
Krosl et al., In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nat Med. Nov. 2003;9(11):1428-32.
[cited by applicant]
Kucharzewska et al., Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. PNAS. Apr. 30, 2013;110(18):7312-7317.
[cited by applicant]
Lai et al., Animal models of diabetic retinopathy: summary and comparison. J Diabetes Res. 2013;2013:106594. 29 pages.
[cited by applicant]
Laine et al., MicroRNAs miR-96, miR-124, and miR-199a regulate gene expression in human bone marrow-derived mesenchymal stem cells. J Cell Biochem. Aug. 2012;113(8):2687-95.
[cited by applicant]
Lanza et al., Extension of cell life-span and telomere length in animals cloned from senescent somatic cells. Science. 2000;288(5466):665-669.
[cited by applicant]
Lanza et al., Human therapeutic cloning. Nat Med. Sep. 1999;5(9):975-7.
[cited by applicant]
Laping et al., Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol. Jul. 2002;62(1):58-64.
[cited by applicant]
Laposa, Stem cells for drug screening. J Cardiovasc Pharmacol. Sep. 2011;58(3):240-5.
[cited by applicant]
Le Grand et al., Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration. J Cell Biol. Sep. 3, 2012;198(5):815-32.
[cited by applicant]
Ledford, Reversal of biological clock restores vision in old mice. Nature. Dec. 2020;588(7837):209.
[cited by applicant]
Lee et al., Deletion of heart-type cytochrome c oxidase subunit 7a1 impairs skeletal muscle angiogenesis and oxidative phosphorylation. J Physiol. Oct. 15, 2012;590(20):5231-43.
[cited by applicant]
Lee et al., Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. Nov. 27, 2012;126(22):2601-11.
[cited by applicant]
Lee et al., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A. Apr. 28, 1998;95(9):5199-204.
[cited by applicant]
Levenberg et al., Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. Apr. 2, 2002;99(7):4391-6.
[cited by applicant]
Levenberg et al., Endothelial potential of human embryonic stem cells. Blood. Aug. 1, 2007;110(3):806-14.
[cited by applicant]
Li et al., Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells. Apr. 2008;26(4):864-73.
[cited by applicant]
Limbourg et al., Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia. Nat Protoc. 2009;4(12):1737-48.
[cited by applicant]
Lin et al., Quantum dot imaging for embryonic stem cells. BMC Biotechnol. Oct. 9, 2007;7:67. 10 pages.
[cited by applicant]
Lin et al., Unregulated miR-96 induces cell proliferation in human breast cancer by downregulating transcriptional factor FOXO3a. PLoS One. Dec. 23, 2010;5(12):e15797. 10 pages.
[cited by applicant]
Liu et al., CD31: beyond a marker for endothelial cells. Cardiovasc Res. Apr. 1, 2012;94(1):3-5.
[cited by applicant]
Liu et al., MiR-106b and MiR-15b modulate apoptosis and angiogenesis in myocardial infarction. Cell Physiol Biochem. 2012;29(5-6):851-62.
[cited by applicant]
Lopatina et al., Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal. Apr. 11, 2014;12:26. 12 pa…
[cited by applicant]
Lu et al., Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods. Jun. 2007;4(6):501-9.
[cited by applicant]
Lu et al., Reprogramming to recover youthful epigenetic information and restore vision. Nature. Dec. 2020;588(7836):124-129.
[cited by applicant]
Lu et al., Reversal of ageing- and injury-induced vision loss by Tet-dependent epigenetic reprogramming. bioRxiv, retrieved nline at: httgs://www.biorxiv.org/content/10.1101/710210v1.full.9df. 51 pages, Jul. 31, 2019.
[cited by applicant]
Lu et al., Targeting of embryonic stem cells by peptide-conjugated quantum dots. PLoS One. Aug. 10, 2010;5(8) :e12075. 10 pages.
[cited by applicant]
Lyden et al., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. Nov. 2001;7(11):1194-201.
[cited by applicant]
Mali et al., Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts. Stem Cells. Aug. 2008;26(8):1998-2005.
[cited by applicant]
Marion et al., Common Telomere Changes during In Vivo Reprogramming and Early Stages of Tumorigenesis. Stem Cell Reports. 2017;8(2):460-475.
[cited by applicant]
Martinez et al., Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol. Mar. 2005;288(3):H1004-9.
[cited by applicant]
Martinez-Redondo et al., Tailored chromatin modulation to promote tissue regeneration. Semin Cell Dev Biol. Jan. 2020;97:3-15, pre-publication edition.
[cited by applicant]
Menendez et al., Metabolic control of cancer cell stemness: Lessons from iPS cells. Cell Cycle. 2015;14(24):3801-11.
[cited by applicant]
Molek et al., Peptide phage display as a tool for drug discovery: targeting membrane receptors. Molecules. Jan. 21, 2011;16(1):857-87.
[cited by applicant]
Mosteiro et al., Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science. Nov. 25, 2016;354(6315):aaf4445, 12 pages.
[cited by applicant]
Nakagawa et al., Reprogramming of somatic cells to pluripotency. Adv Exp Med Biol. 2010;695:215-24.
[cited by applicant]
Nakashiba et al., Netrin-G1: a novel glycosyl phosphatidylinositol-linked mammalian netrin that is functionally divergent from classical netrins. J Neurosci. Sep. 1, 2000;20(17):6540-50.
[cited by applicant]
Naldini et al., In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. Apr. 12, 1996;272(5259):263-7.
[cited by applicant]
Nedergaard et al., PPARgamma in the control of brown adipocyte differentiation. Biochim Biophys Acta. May 30, 2005;1740(2):293-304.
[cited by applicant]
Nelson et al., Induced pluripotent stem cells: advances to applications. Stem Cells Cloning. Jan. 1, 2010;3:29-37.
[cited by applicant]
Nguyen et al., Lin28 and let-7 in cell metabolism and cancer. Transl Pediatr. Jan. 2015;4(1):4-11.
[cited by applicant]
Nicoli et al., MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature. Apr. 22, 2010;464(7292):1196-200.
[cited by applicant]
Niemeläet al., Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood. Nov. 15, 2005;106(10):3405-9.
[cited by applicant]
Nishio et al., Production of functional classical brown adipocytes from human pluripotent stem cells using specific hemopoietin cocktail without gene transfer. Cell Metab. Sep. 5, 2012;16(3):394-406.
[cited by applicant]
Nonaka et al., Development of stabilin2+ endothelial cells from mouse embryonic stem cells by inhibition of TGFbeta/activin signaling. Biochem Biophys Res Commun. Oct. 17, 2008;375(2):256-60.
[cited by applicant]
Nourse et al., VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Arterioscler Thromb Vasc Biol. Jan. 2010;30(1):80-9.
[cited by applicant]
Nowakowski et al., Genetic engineering of stem cells for enhanced therapy. Acta Neurobiol Exp (Wars). 2013;73(1):1-18.
[cited by applicant]
Ocampo et al., In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell. 2016;167(7):1719-1733.e12.
[cited by applicant]
Odaka, Localization of mesenchymal cells in adult mouse thymus: their abnormal distribution in mice with disorganization of thymic medullary epithelium. J Histochem Cytochem. Apr. 2009;57(4):373-82.
[cited by applicant]
Ofenbauer et al., Strategies for in vivo reprogramming. Curr Opin Cell Biol. Dec. 2019;61:9-15.
[cited by applicant]
Ohno et al., PPAR agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab. Mar. 7, 2012;15(3):395-404.
[cited by applicant]
Ohshima et al., Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. Oct. 8, 2010;5(10):e13247. 10 pages.
[cited by applicant]
Olova et al., Partial reprogramming induces a steady decline in epigenetic age before loss of somatic identity. Aging Cell. 2019;18(1):e12877, 7 pages.
[cited by applicant]
Ong et al., Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation. Sep. 9, 2014;130(11 Suppl 1):S60-9.
[cited by applicant]